Clinical trials referenced in this document:
Funding for this research was provided by:
National Institute on Drug Abuse (3UG1DA040316)
Received: 18 December 2020
Accepted: 3 June 2021
First Online: 15 June 2021
: Ethics approval was obtained from the HealthPartners Institutional Review Board (IRB). Primary care clinicians provided written consent to participate. The IRB granted a waiver of written consent for primary care patients.
: Not applicable.
: Dr. Huntley’s spouse is eligible for a defined benefit plan through Pfizer from previous employment. The remaining authors have no competing interests to disclose.